Jack Slevin
Stock Analyst at Jefferies
(4.19)
# 1,537
Out of 5,090 analysts
44
Total ratings
64.5%
Success rate
21.3%
Average return
Main Sectors:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CON Concentra Group Holdings Parent | Initiated: Buy | $47 | $39.15 | +20.05% | 1 | Oct 16, 2026 | |
| LFST LifeStance Health Group | Reiterated: Buy | $14 → $15 | $12.37 | +21.26% | 2 | Sep 25, 2026 | |
| CVSA Covista | Reiterated: Buy | $175 | $127.24 | +37.54% | 6 | Sep 15, 2026 | |
| MD Pediatrix Medical Group | Downgraded: Hold | $27 → $28 | $27.76 | +0.86% | 5 | Aug 19, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $37 → $53 | $38.03 | +39.36% | 9 | Jun 30, 2026 | |
| AGL agilon health | Upgraded: Buy | $28 → $48 | $88.45 | -45.73% | 8 | May 7, 2026 | |
| USPH U.S. Physical Therapy | Rated: Buy | $102 | $85.98 | +18.63% | 1 | Mar 9, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 → $32 | $22.62 | +41.47% | 6 | Feb 26, 2026 | |
| AMN AMN Healthcare Services | Reiterated: Hold | $22 → $21 | $40.00 | n/a | 4 | Aug 13, 2025 | |
| STLN Starling Oncology | Reiterated: Buy | $2.5 → $2 | $6.91 | n/a | 2 | Jun 10, 2024 |
Concentra Group Holdings Parent
Oct 16, 2026
Initiated: Buy
Price Target: $47
Current: $39.15
Upside: +20.05%
LifeStance Health Group
Sep 25, 2026
Reiterated: Buy
Price Target: $14 → $15
Current: $12.37
Upside: +21.26%
Covista
Sep 15, 2026
Reiterated: Buy
Price Target: $175
Current: $127.24
Upside: +37.54%
Pediatrix Medical Group
Aug 19, 2026
Downgraded: Hold
Price Target: $27 → $28
Current: $27.76
Upside: +0.86%
Astrana Health
Jun 30, 2026
Reiterated: Buy
Price Target: $37 → $53
Current: $38.03
Upside: +39.36%
agilon health
May 7, 2026
Upgraded: Buy
Price Target: $28 → $48
Current: $88.45
Upside: -45.73%
U.S. Physical Therapy
Mar 9, 2026
Rated: Buy
Price Target: $102
Current: $85.98
Upside: +18.63%
Privia Health Group
Feb 26, 2026
Reiterated: Buy
Price Target: $30 → $32
Current: $22.62
Upside: +41.47%
AMN Healthcare Services
Aug 13, 2025
Reiterated: Hold
Price Target: $22 → $21
Current: $40.00
Upside: n/a
Starling Oncology
Jun 10, 2024
Reiterated: Buy
Price Target: $2.5 → $2
Current: $6.91
Upside: n/a